Butyrate reduces the production of proinflammatory molecules such as iNOS, TNF-α, MCP-1, IL-12, and IL-6 [96,98] and has previously been associated with beneficial effects on the pathogenesis of MS [99,100,101]. This evidence concerns the gene TNF and myeloid sarcoma.